New to Meducation?
Sign up
Already signed up? Log In
view moderators

Immunotherapy

Category

Preview
0
3

Immunotherapy Shows Encouraging Results in Neuroblastoma

An experimental monoclonal antibody, added to chemotherapy, achieved an 89% response rate in a small early study.  
medscape.com
over 4 years ago
Preview
0
7

Lung Cancer Sessions Focus on Immunotherapy, Genomics

From diagnosis using molecular markers to targeted treatment, Dr Mark Kris details which studies from ASCO 2016 he thinks will help clinicians and patients fight lung cancer.  
medscape.com
over 4 years ago
Preview
0
1

What's Hot at ASCO 2016?

Continuing excitement over immunotherapy and new research on precision medicine are among the highlights. Come and visit Medscape at booth 6053.  
medscape.com
over 4 years ago
Preview
0
2

One Honest Researcher and More Talk of Cure for Melanoma

During a press conference, a pembrolizumab investigator was open and honest about comparisons with rival immunotherapy nivolumab and her hope for some special patients.  
medscape.com
over 4 years ago
Preview
0
2

FDA Approves Atezolizumab for Bladder Cancer

Atezolizumab is the first and only anti-PDL1 cancer immunotherapy. It is also the first new treatment option in metastatic bladder cancer in more than 30 years.  
medscape.com
over 4 years ago
Preview
0
1

Immunotherapy in the Prevention of Alzheimer Disease

Dr Jacobs reviews the results of a recent study evaluating passive immunotherapy with encapsulated cell implants to target misfolded proteins in the prevention of Alzheimer disease.  
medscape.com
over 4 years ago
Preview
0
2

Melanoma: Survival Curve 'Tail' Getting Longer

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.  
medscape.com
over 4 years ago
Preview
0
8

New Immunotherapies Bring New Questions in Lung Cancer

Dr Mark Kris assesses the complicated risks and benefits of using nivolumab and pembrolizumab for patients with lung cancers.  
medscape.com
over 4 years ago
Preview
0
6

Immunotherapy tablet helps control asthma in people with house dust mite allergy

Patients with house dust mite allergy related asthma showed improvements in asthma control when given sublingual allergen immunotherapy on top of their usual medicine, research published in JAMA has found.1  
feeds.bmj.com
over 4 years ago
Preview
0
1

Yellow fever vaccination essential for Angola, WHO reminds travellers

26 APRIL 2016 | GENEVA - As efforts to bring an outbreak of yellow fever in Angola under control continue, WHO is reminding all travellers to the country that they are required to receive the yellow fever vaccination and to have a valid certificate of vaccination to prove that they are protected from the disease and to prevent its further spread.  
who.int
over 4 years ago
Preview
0
0

Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC

PD-L1 expression in tumors is being used to guide decisions on immunotherapy. With several tests available, how do these assays compare?  
medscape.com
over 4 years ago
Preview
0
1

World Immunization Week 2016: Immunization game-changers should be the norm worldwide

During World Immunization Week 2016, WHO highlights recent gains in immunization coverage, and outlines further steps countries can take to “Close the Immunization Gap” and meet global vaccination targets by 2020.  
who.int
over 4 years ago
Preview
0
0

Downside to Melanoma Immunotherapy: 55% to 67% Nonresponders

The efficacy of anti-PD-1 agents for advanced melanoma, such as pembrolizumab, has been great news, but not for all patients.  
medscape.com
over 4 years ago
Preview
0
4

'Remarkable' Responses in Rare Merkel-Cell Skin Cancer

The first-ever positive clinical trial in the rare Merkel-cell carcinoma shows the highest responses to immunotherapy yet seen, in 56% of patients.  
medscape.com
over 4 years ago
Preview
0
1

Hope for Advanced HNSCC at Last From Immunotherapy

Nivolumab significantly improved survival for patients with advanced refractory head and neck cancer.  
medscape.com
over 4 years ago
Preview
0
1

CD4 T-cell Immunotherapy Shows Activity in Solid Tumors

The first immunotherapy to use genetically engineered CD4 T-cells and targeting MAGE-A3 showed activity against several advanced solid cancers.  
medscape.com
over 4 years ago
Preview
0
0

More Patients Living Longer: Latest Immunotherapy Data

The latest data for survival on nivolumab are better than those previously seen with ipilimumab, and both show that some patients live for years.  
medscape.com
over 4 years ago
Preview
0
0

Skin cancer: Pair of drugs 'eliminate 20% of tumours' - BBC News

A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows.  
bbc.co.uk
over 4 years ago
Preview
0
0

Announcement: National Infant Immunization Week — April 16–23, 2016

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).  
cdc.gov
over 4 years ago
Preview
0
0

Sean Parker Sets up $250 Mln Cancer Immunotherapy Collaboration

A $250 million grant from Silicon Valley billionaire Sean Parker, announced on Wednesday, aims to speed development of more effective cancer treatments by fostering collaboration among leading researchers in the field.  
medscape.com
over 4 years ago